TrialClinical cancer research : an official journal of the American Association for Cancer Research2019

Pharmacodynamic and Clinical Results from a Phase I/II Study of the HSP90 Inhibitor Onalespib in Combination with Abiraterone Acetate in Prostate Cancer.

Susan Slovin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.